ROPIVACAINE B.BRAUN 2 mg/ml, solution for injection/for infusion 10 bags of 100 ml
Active ingredients: (S)-N-(2,6-dimethylphenyl)-1-ethylpiperidine-2-carboxamide
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection or infusion10 bags of 100 mlpéridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROPIVACAINE B.BRAUN 2 mg/ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- péridurale;périneurale
- Presentation description
- 10 poche(s) polyéthylène de 100 ml
- Marketing authorisation holder
- B BRAUN MELSUNGEN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Jun 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66104277CIP75505758CIP133400955057581Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPIVACAÏNE MONOHYDRATÉsolution | 2 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.